Home > Result Summaries: Compounds > naratriptan > Result Summary for S2WB1002

Result Summary for S2WB1002

Result Summary

Protocol ID:	S2WB1002
Clinical Study ID:	S2WB1002
Official Title:	A study to compare the safety, tolerability, pharmacodynamics and pharmacokinetics of two doses of oral naratriptan (GR85548A) in young and elderly subjects.
Phase:	Phase 1
Study Indications or Diseases:	Migraine Disorders
Generic Name:	naratriptan
Trade/Product Name:	amerge;naramig
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Abstract: The safety, tolerability and pharmacokinetics of oral naratriptan in healthy subjects. Kempsford, R D, Hoke, J F, and Huffman, C S 8th Congress of the International Headache Society 6/10/1997 Amsterdam, Netherlands. Abstract; special population Kempsford R, J of Neurol. Sciences 1997;150(suppl):S168 Abstract: The safety, tolerability, and pharmacokinetics of oral naratriptan in healthy subjects. Kempsford, RD MD, Hoke, JF MD, and Huffman, CS MD 39th Annual Scientific Meeting of the American Association for the Study of Headache 6/22/1997 New York, New York Abstract: The safety, tolerability, pharmacodynamics and pharmacokinetics of naratriptan in healthy elderly subjects R. Kempsford, E. Fuseau, J. Moss, P. Bryson 16th World Congress of Neurology 9/14/1997 Buenos Aires, Argentina